Key result
Endostatin and radiotherapy shrink nodules and yield 18-month survival in a pulmonary arterial sarcoma case.
Why the study?
Does endostatin injection combined with radiotherapy reduce tumor size in primary pulmonary arterial sarcoma?
Case Report (n=1)
No
Does endostatin injection combined with radiotherapy reduce tumor size in primary pulmonary arterial sarcoma?
Endostatin injection combined with radiotherapy may be a viable alternative treatment for primary pulmonary arterial sarcoma.
May suggest response in one case; leaves open any therapeutic role for endostatin plus radiotherapy in pulmonary arterial sarcoma.
We present a case of primary pulmonary arterial sarcoma (PPAS) treated with endostatin (endostar) injection and radiotherapy discuss the diagnosis, clinical manifestations, and pathology of PPAS. The patient complained of cough with sputum, fever, and chest pain with hemoptysis. Numerous nodules were observed in the computed tomography (CT) scan. The patient was diagnosed with pulmonary embolism (PE) by computed tomography pulmonary angiography (CTPA). The pathology and immunohistochemistry results indicated soft tissue sarcomas, indicative of angiosarcoma. The nodules shrunk after 5 courses of endostatin and one course of radiotherapy, as determined in the CT scan. Primary pulmonary arterial sarcoma is clinically rare with nonspecific symptoms. Hence, it can be easily misdiagnosed as PE, and biopsy must be performed for confirmation. Current treatment methods, including surgery, are limited. Therefore, administration of endostatin injection combined with other therapies may be an alternative treatment methods.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2020) conducted a case report in Primary pulmonary arterial sarcoma (PPAS) (n=1). Endostatin (endostar) injection and radiotherapy was evaluated on Tumor response and survival. Endostatin injection combined with radiotherapy resulted in significant shrinkage of pulmonary nodules and a total survival duration of 18 months in a patient with primary pulmonary arterial sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: